We are live on ! Find out more
OFA

Oak Family Advisors Portfolio holdings

AUM $391M
1-Year Est. Return 26.35%
This Fund
S&P 500
This Quarter Est. Return
+2.54%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.49%
5 Year Est. Return
+109.52%
10 Year Est. Return
AUM
$364M
AUM Growth
-$35.6M
Cap. Flow
-$43.2M
Cap. Flow %
-11.86%
Top 10 Hldgs %
37.95%
Holding
126
New
15
Increased
32
Reduced
52
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 19.53%
2 Healthcare 10.53%
3 Industrials 9.62%
4 Communication Services 6.04%
5 Financials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLC icon
126
PUT
State Street Communication Services Select Sector SPDR ETF
XLC
$22.4B
-2,000
Closed -$237K

Similar funds

Oak Family Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Oak Family Advisors held 126 positions worth $364M, down 8.9% from $400M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Oak Family Advisors withdrew a net $43.2M in Q4 2025, closing 15 positions and reducing 52 holdings. Its most notable exit was Nice, an estimated $4.06M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Oak Family Advisors opened a new position in Kenvue worth $6M.

  • Oak Family Advisors's largest Q4 2025 buy was Kenvue: 348,025 shares worth $6M.
  • Oak Family Advisors added most to Novo Nordisk in Q4 2025, an estimated $6.19M increase.
  • Oak Family Advisors's biggest Q4 2025 reduction was Zimmer Biomet, cutting an estimated $3.58M.
  • Oak Family Advisors fully exited Nice in Q4 2025, selling an estimated $4.06M.
  • Oak Family Advisors's ten largest holdings make up 38% of its $364M portfolio in Q4 2025.
  • Oak Family Advisors opened 15 new positions and closed 15 in Q4 2025.
  • Oak Family Advisors's portfolio value fell 8.9% quarter-over-quarter to $364M.

Based on Oak Family Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.